This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
CARD Trial
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Advanced Bladder Cancer
JAVELIN Bladder 100 Trial
Centers of Excellence
Urologic Oncology
Left Group
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Neal Shore, MD, FACS
PSMA-Targeted Therapy
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Clinical Trials
From the Editor
Search Clinical Trials
Transformative Trials
DORA - PCCTC
IRONMAN - PCCTC
PROMISE - PCCTC
SPLASH Trial
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
APCCC 2022
AUA 2022
Upcoming
ASCO 2022
EAU 2022
See All
See All Conference Coverage
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Conferences
Recent Abstracts
Bayer to Present Key Data Across Oncology Portfolio Showcasing Significant Advances in Cancer Care at 2022 ASCO Annual Meeting
May 19, 2022
AUA 2022: Surrogate Endpoints as Predictors of Survival in Metastatic Urothelial Cancer Trials
May 18, 2022
AUA 2022: Frequency of Fibroblast Growth Factor Receptor Alterations and Association With Bacillus Calmette-Guerin Outcomes in a Real-World Genomic Analysis of High-Risk Non-Muscle-Invasive Bladder Cancer (GARNER) Study
May 18, 2022
AUA 2022: Longitudinal Health-Related Quality of Life Outcomes in Adults with Non-Muscle-Invasive Bladder Cancer Receiving a Chemoablative Gel as a Primary Treatment (Optima II: Phase 2b, single arm, open-label trial)
May 18, 2022
AUA 2022: A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating BCG Unresponsive Non-Muscle Invasive Bladder Cancer: Recirculant Hyperthermic Intravesical Chemotherapy
May 18, 2022
AUA 2022: Neoadjuvant Pembrolizumab May Result in Long-Term Outcome Improvement in Biomarker-Unselected Patients With Muscle-Invasive Bladder Cancer: Updated Results From: Updated results from PURE-01
May 18, 2022
AUA 2022: Prevalence and Predictors of Psychological Distress Among Patients Treated for Bladder Cancer
May 18, 2022
AUA 2022: Evaluating Intravesical Nadofaragene Firadenovec and Immune Checkpoint Blockade Combination Therapy in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Evidence From a Phase 3 Trial
May 18, 2022
AUA 2022: Immediate Radical Cystectomy vs. BCG Immunotherapy for T1 High Grade Non-Muscle-Invasive Bladder Cancer: an International Multicentre Collaboration
May 18, 2022
AUA 2022: CORE1: Phase 2, Single Arm Study of CG0070 Combined with Pembrolizumab in Patients with Non Muscle Invasive Bladder Cancer Unresponsive to BCG
May 18, 2022
AUA 2022: A Phase II Study of Check Point Inhibitor, Durvalumab (MEDI4736) for Bacillus Calmette-Guerin Unresponsive Carcinoma in Situ of the Bladder
May 18, 2022
AUA 2022: Two-Year Efficacy Follow-Up of a Phase I Trial of Intravesical BCG Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade NMIBC after Previous BCG Treatment
May 18, 2022
AUA 2022: Development of Patient-Derived Kidney Cancer Organoid; Application to Drug Screening Models and Its Challenges
May 18, 2022
AUA 2022: The Patient Voice: Experiences with Ureteral Stent Removal – A Urinary Stone Disease Research Network (USDRN) Study
May 18, 2022
AUA 2022: Determining the Threshold of Safety for Intrarenal Pressure During Flexible Ureteroscopy Using an in Vivo Pig Model
May 18, 2022
AUA 2022: Outcomes of Cytoreductive Nephrectomy Followed by Active Surveillance in Metastatic Renal Cell Carcinoma
May 18, 2022
AUA 2022: 68 Ga-PSMA PET/CT for Preoperative Lymph Node Staging of High Risk Prostate Cancer
May 18, 2022
AUA 2022: Can Pelvic Lymph Node Dissection Be Omitted at the Time of Radical Prostatectomy in Patients With a Negative Preoperative 68Ga-PSMA PET/CT? The Importance of Patient Risk Stratification According to Individual Risk of Lymph Node Metastases
May 18, 2022
AUA 2022: Final Results of a Phase I Trial of WST11 (TOOKAD Soluble) Vascular-Targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma
May 18, 2022
AUA 2022: Impact of Node Count on Survival Outcomes of Lymph Node Dissection in non-Metastatic Upper Tract Urothelial Carcinoma: Analysis of the ROBUUST Registry
May 17, 2022
Page 1 of 465
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free